Please ensure Javascript is enabled for purposes of website accessibility

Solutions

Go from molecule to market with one CMC development team

Make faster decisions, reduce risk, and unlock new opportunities with the only global development, research, and manufacturing partner dedicated exclusively to animal health.

200+

projects supported through to registered products

3

EMA- and FDA-approved GMP manufacturing facilities

125+

commercial products manufactured

50+

countries supplied

100+

veterinarians and clinical trial staff

Your entire CMC development programme. One ecosystem.

Splitting your animal health product development across separate research, development, and manufacturing partners leads to more handoffs, slower decision-making, and costly late-stage surprises. 

Instead, bring every stage into one ecosystem, with your teams aligned from the first study, so you can:

  • Design smarter studies, informed by manufacturing and regulatory input
  • Build manufacturability into your formulation before scale-up
  • Design smarter studies, informed by manufacturing and regulatory input
  • Reach market on a more predictable path, with less rework

Development · CDO

Turn your molecule into a product you can manufacture, with formulation, analytical, and process development across a wide range of dosage forms.

Research · CRO

Generate the preclinical and clinical data your registration needs, from first-in-animal studies to GCP field trials.

Manufacturing · CMO

Move your product into GMP manufacturing and supply your market at a commercial scale.

Take on more with one partner, from feasibility to full-scale supply

Know your odds before you invest

Get high-level and detailed risk assessments, including projected technical and commercial probabilities of success, to support your funding strategy.

Test in your target species from day one

Run pharmacokinetic, palatability, and challenge studies in our own AAALAC-accredited ABSL-2 facilities, then take your product into clinical studies across species from cats, dogs, and horses to cattle, poultry, aquaculture, and even bees.

Run field trials on the batches we just made

Your GCP field studies are supplied directly from our scale-up and registration batches, so test articles never have to move between partners.

Combine several APIs in one long-acting dose

License our controlled-release intraruminal capsule, long-acting microspheres, or soft chew technology to differentiate a new molecule or extend the life of an existing product.

Manufacture the products others turn away

Bring us hormone products, controlled drugs, and flammable liquids, all manufactured in our own GMP facilities.

Scale to millions of doses

Manufacture across four GMP sites with capacity for 12 million litres of liquids, 400 tonnes of solid dose, and 20 million controlled-release capsules.

Stay coordinated from first study to commercial supply

Your CMC development programme follows a single plan, with one Argenta project team accountable for timelines and deliverables at every stage.Our four EMA- and FDA-approved, GMP-compliant sites can support your product at every stage—from formulation and delivery systems to packaging—ensuring quality, scalability, and efficiency.
‍
A named alliance manager keeps your leadership and ours aligned across all your programmes and sites, chairs regular governance reviews, and handles escalations as they arise.

When you’re ready to file, our in-house regulatory affairs team can help compile the CMC, safety, efficacy, and food safety sections with your team, so you submit a single coordinated dossier.

See the support your product gets at every stage

CMC development spans six stages, and each stage pairs with a clinical or regulatory milestone in a parallel workstream. Our team can run both streams for you, or work alongside your own clinical partners if you prefer.

1. Proof of concept

Find out whether your product idea is scientifically and practically feasible, as well as which risks could stop it, before you commit further investmen
Explore proof of concept
Runs alongside pilot and feasibility studies in our in-house companion and farm animal models, with early data feeding straight into your formulation decisions
Explore pre-clinical studies

2. Product optimisation

Lock a formulation and manufacturing process backed by your pharmacokinetic, stability, and, for companion animal oral products, palatability results.
Explore early phase development
Runs alongside target animal safety studies, often in the same in-house animal models used in Stage 1
Explore clinical studies

3. Pilot scale-up

Scale your lead formulation to around one-tenth of commercial scale and generate the data regulators need to justify every critical process parameter.
Explore process development
Runs alongside target animal effectiveness and field studies, run by our own clinical trial team with product supplied from these batches
Explore clinical studies

4. Product registration

Submit a CMC dossier built on validated analytical methods, GMP registration batches, and at least six months of stability data.
Explore analytical development
Runs alongside field trials on test article from your registration batches, while our regulatory affairs team helps compile the full dossier as one coordinated submission
Explore regulatory affairs

5. Technology transfer

Move your validated product to the manufacturing site you need, whether that’s into Argenta, between our sites, or out to another partner.
Explore technology transfer
Runs alongside regulatory submission review, with our regulatory affairs team answering authority queries while the receiving site is qualified, so manufacturing capacity is ready the moment approval lands
Explore regulatory affairs

6. Commercialisation

Supply your market reliably at commercial scale, with ongoing stability monitoring and quality oversight.
Explore contract manufacturing
Runs alongside post-approval surveillance and lifecycle management, with our regulatory affairs team supporting any label or dossier updates
Explore pharmacovigilance

Products like yours have reached market across molecules, modalities, and geographies

More than 200 veterinary drug development projects have made the journey with us to registered products. Some ran with us from proof of concept to commercialisation, while others joined partway or moved on to external manufacturing. Whichever route fits your product, you get fewer handoffs and faster decisions at every stage you run with us.

Start anywhere, benefit everywhere

Whether you’re an established animal health company or a start-up, you can start at any stage, work with us on your terms, and choose the engagement model that fits your funding:

  • Fee-for-service: choose the individual services you need, from pharmaceutical sciences to commercial manufacture
  • Turnkey product development: hand over development from pharmaceutical sciences through technology transfer, funded by you
  • Risk and reward product development: partner with us across the full pathway, supported by external funding
Talk to our experts

Not sure if your idea is ready?
‍
Start with an opportunity assessment to decide whether, and how, to take your product idea forward.

Opportunity assessment

Find your fastest route to market

Tell us where your product sits today, and our experts will help you plan the route from there to commercial supply.
Talk to our expertsDownload the Molecule to Market ebook
Clinical-stage terms on this page align with recognised international frameworks, including US FDA Center for Veterinary Medicine (CVM) and VICH guidelines. The stage pairing reflects Argenta’s general view of how CMC and clinical timelines line up and is not an official regulatory crosswalk; programme-specific regulatory sign-off is recommended.

Many parts,
one partner

Throughout the entire lifecycle — from concept to commercialisation — Argenta partners with you to navigate product development complexities and maximise chances of success. Our flexible model means you can engage with only the services you need, whether that’s all of them or just one.

Wherever you are in your product development journey, Argenta is here to help.

Contact Our Experts Today

A considered approach: Minimising financial risk, maximising visibility

Product development is a complex and costly endeavour. But with our staged approach, we help decrease financial risk early in the product lifecycle, giving you product development peace of mind.

And, with 200+ years of collective experience, our multidisciplinary team ensures you know what to expect at every stage.

Start your journey. Connect with our team today.